A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 28 (4), 385-397
- https://doi.org/10.1016/0010-7824(83)90040-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera®) as a contraceptive agentActa Endocrinologica, 1982
- Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipillContraception, 1982
- A COMPREHENSIVE REVIEW OF INJECTABLE CONTRACEPTION WITH SPECIAL EMPHASIS ON DEPOT MEDROXYPROGESTERONE ACETATEThe Medical Journal of Australia, 1981
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPAJournal of Clinical Endocrinology & Metabolism, 1977
- EFFECTS OF PROGESTINS ON ESTRADIOL RECEPTOR LEVELS IN HUMAN ENDOMETRIUMJournal of Clinical Endocrinology & Metabolism, 1975
- Depot-medroxyprogesterone acetate as a contraceptive agent: Return of fertility after discontinuation of useContraception, 1973
- PROLONGED SECONDARY AMENORRHŒA AFTER ORAL CONTRACEPTIVE THERAPY: Natural and Unnatural HistoryThe Lancet, 1971
- A cross-sectional study of plasma FSH and LH levels in women using sequential, combination or injectable steroid contraceptives over long periods of timeContraception, 1970